Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

International journal of cancer - 1 Oct 2015

Saadatmand Sepideh, Obdeijn Inge-Marie, Rutgers Emiel J, Oosterwijk Jan C, Tollenaar Rob A, Woldringh Gwendolyn H, Bergers Elisabeth, Verhoef Cornelis, Heijnsdijk Eveline A, Hooning Maartje J, de Koning Harry J, Tilanus-Linthorst Madeleine M

Abstract excerpt

Adding MRI to annual mammography screening improves early breast cancer detection in women with familial risk or BRCA1/2 mutation, but breast cancer specific metastasis free survival (MFS) remains unknown. We compared MFS of patients from the largest prospective MRI Screening Study (MRISC) with 1:1 matched controls. Controls, unscreened if<50 years, and screened with biennial mammography if ≥50 years, were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genes, BRCA1

Share to Genetic Predisposition to Disease

Share to Magnetic Resonance Imaging

Share to Mutation

Share to Netherlands

Source

Identifiers

PMID: 25820931
DOI: 10.1002/ijc.29534

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).PMID 25820931Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.Semantic proximity Read ↗

MRI breast screening in high-risk women: cancer detection and survival analysis.Semantic proximity Read ↗

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.Semantic proximity Read ↗

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

Advances in Risk Management and Screening for Women at Increased Risk of Breast Cancer: The Role of MR Imaging and Personalised Approaches.Semantic proximity Read ↗

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.Semantic proximity Read ↗

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.Semantic proximity Read ↗

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.Semantic proximity Read ↗

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.Semantic proximity Read ↗

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.